With a market cap of $8.5 billion, Conagra Brands, Inc. (CAG) is a leading consumer packaged foods company headquartered in Chicago, Illinois. Its diversified portfolio spans more than 70 well-known brands, including Birds Eye, Duncan Hines, Slim Jim, Healthy Choice, and Reddi-Wip, with operations across grocery, snacks, frozen, refrigerated, international, and foodservice channels serving both retail and commercial customers. Companies worth between $2 billion and $10 billion or more are typically class ...

Core Insights - Thompson, Siegel, and Walmsley (TSW) has increased its stake in Conagra Brands, making it the 7th-largest holding in their portfolio, with a total position of 5,269,532 shares valued at $96.48 million as of the end of the third quarter [1][2]. Company Overview - Conagra Brands is a leading North American packaged foods company with a diversified product lineup and strong brand portfolio [6]. - The company reported a trailing twelve months (TTM) revenue of $11.45 billion and a net income of $850.10 million, with a dividend yield of 8.13% [4]. Recent Performance - As of December 1, 2025, Conagra Brands shares were priced at $17.22, reflecting a 33% decline over the prior year and underperforming the S&P 500 by 49 percentage points [3]. - The stock is currently trading at 0.7 times sales, the lowest since 2015, and at 7 times free cash flow, close to its lowest in the last two decades [11]. Investment Rationale - TSW's investment in Conagra aligns with a value investing strategy, as the company is seen as stable despite declining sales growth rates and challenges from GLP-1 medicines impacting food companies [10]. - The company holds $7.5 billion in long-term debt against a market capitalization of $8.2 billion, necessitating continued debt repayment to ensure the safety of its high-yield dividend and overall company longevity [12]. Product Portfolio - Conagra offers a broad portfolio of branded packaged foods, including frozen meals, snacks, and shelf-stable grocery products under well-known brands such as Birds Eye, Duncan Hines, Healthy Choice, and Slim Jim [9]. - The company generates revenue primarily through the manufacturing and distribution of consumer food products across various channels, leveraging scale and brand recognition [9].

Core Insights - Conagra Brands, a 105-year-old company with over 20 national food brands, is projected to achieve more than $11.6 billion in sales this year while modernizing its portfolio for future growth [1] - The company's stock has declined 37% year-to-date, making it one of the worst performers in the S&P 500, which has resulted in an increased dividend yield of 8% [2] - Conagra has a trailing payout ratio of 78% and has increased its dividend for the past six years, indicating a commitment to returning value to shareholders [7] Conagra Brands - Conagra is focusing on modernizing its product offerings to drive future growth [1] - The company has experienced a significant stock decline, which has led to a high dividend yield, attracting value investors [2] - The dividend payments from Conagra are projected to grow, with historical growth rates averaging 6.3% annually over the past five years [3] - The current dividend yield of Conagra is significantly higher than the S&P 500 average of 1.2% [5] - Conagra's price-to-earnings (P/E) and price-to-sales (P/S) ratios are near 10-year lows, suggesting potential value [7] United Parcel Service (UPS) - UPS has also faced a challenging year, with a 28% decline in stock price, resulting in a dividend yield of almost 7% [8] - The company has maintained or increased its dividend annually since going public in 1999, reflecting its financial strength [9] - UPS's dividend payout ratio is currently at 91%, but it is expected to decrease as earnings per share (EPS) are projected to grow by 4% and 11% in 2026 and 2027, respectively [10] Pfizer - Pfizer's stock has seen a modest decline of 5% year-to-date, with a current dividend yield of 6.9%, the highest in the healthcare sector [11] - The company has a 98% dividend payout ratio, which is projected to decline to 75% by 2026, indicating potential for sustainable dividends [12] - Pfizer has a strong track record of dividend increases over the past 16 years, supported by its balance sheet strength [12] Verizon - Verizon offers a dividend yield of 6.7%, making it one of the top dividend payers in the S&P 500 [13] - The company has a commitment to returning value to shareholders, with a 21-year track record of annual dividend increases [14] - Verizon's current P/E ratio is less than 9 times earnings for the next 12 months, indicating potential undervaluation [15]

Core Viewpoint - Conagra Brands, Inc. is facing significant stock underperformance despite a strong market position and positive quarterly results, with ongoing challenges from inflation and tariffs impacting future earnings expectations [1][2][4]. Company Overview - Conagra Brands has a market capitalization of $8.2 billion and operates in the North American packaged foods sector with a diverse brand portfolio including Birds Eye, Healthy Choice, Slim Jim, Reddi-wip, and Marie Callender's [1]. - The company operates across four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice, focusing on innovative food products that cater to changing consumer preferences [1]. Stock Performance - Over the past 52 weeks, Conagra's stock has decreased by 41.1%, significantly underperforming the S&P 500 Index, which has increased by 18.5% during the same period [2]. - Year-to-date, the stock is down 38.3%, while the S&P 500 has risen by 15.1% [2]. Recent Financial Results - On October 1, Conagra reported Q1 2026 revenue of $2.63 billion and adjusted EPS of $0.39, exceeding expectations [4]. - The company has maintained its annual forecasts despite facing inflation and tariff pressures, indicating confidence in its pricing actions and cost-saving initiatives to offset rising costs [4]. Earnings Expectations - For the fiscal year ending in May 2026, analysts project a 23.5% year-over-year decrease in adjusted EPS to $1.76 [5]. - Conagra's earnings surprise history is mixed, with two beats and two misses in the last four quarters [5]. Analyst Ratings - Among 17 analysts covering Conagra, the consensus rating is a "Hold," with two "Strong Buy," 13 "Holds," one "Moderate Sell," and one "Strong Sell" [5]. - Morgan Stanley has set a price target of $21, with a mean price target of $20.53 indicating a nearly 20% premium to current levels, while the highest target of $27 suggests a potential upside of 57.8% [6].

Core Insights - The consumer goods sector is currently facing pressure due to macroeconomic concerns, but many stocks are oversold, presenting potential investment opportunities [2][3] Group 1: Conagra Brands - Conagra Brands is a packaged foods company known for brands like Duncan Hines and Healthy Choice, facing negative sentiment due to inflation, low growth, and high debt [5] - The company trades at a forward P/E ratio of 10.9, which is lower than peers like General Mills at 13.8, indicating potential for valuation improvement [6] - Conagra offers a forward dividend yield of 7.5%, providing steady returns while awaiting a turnaround [6][8] Group 2: Keurig Dr. Pepper - Keurig Dr. Pepper is under market pressure due to concerns over its $18 billion acquisition of JDE Peet's and subsequent plans to split into two companies [9] - The transaction is seen as complex but has the potential to unlock and create value, with the stock trading at less than 12 times forward earnings, a discount compared to industry peers [10]

Core Insights - Conagra Brands Inc. reported first-quarter fiscal 2026 results that exceeded Wall Street expectations but showed year-over-year declines in key metrics [1][2] Financial Performance - The company achieved net sales of $2.63 billion, a decrease of 5.8% compared to the prior-year period, while adjusted earnings per share were 39 cents, down 26.4% [2] - Wall Street analysts had anticipated net sales of $2.62 billion and earnings of 33 cents per share [3] Sales Breakdown - The decline in net sales was attributed to a 5.1% impact from mergers and acquisitions, a 0.6% drop in organic sales, and a minor 0.1% foreign exchange effect [3] - Within organic sales, a 0.6% price/mix benefit was more than offset by a 1.2% decline in volume [4] Segment Performance - Grocery & Snacks revenue fell 8.7% to $1.1 billion, with a 1.0% decline in organic net sales [6] - Refrigerated & Frozen sales decreased 0.9% to $1.1 billion, but organic net sales rose 0.2% due to a 0.5% increase in volume [6] - International segment revenue declined 18% to $212 million, with organic net sales down 3.5% [7] - Foodservice sales dipped 0.8% to $264 million, while organic net sales rose 0.2% [7] Cash Position - Conagra reported cash and cash equivalents of $698.1 million at the end of the first quarter of fiscal 2026 [4] Management Commentary - The CEO highlighted successful supply chain objectives and a focus on disciplined execution amid ongoing inflationary pressures and cautious consumer sentiment [5] Outlook - For fiscal 2026, the company reaffirmed guidance, projecting organic net sales growth between -1% and 1%, an adjusted operating margin of 11.0%–11.5%, and adjusted EPS of $1.70–$1.85 [8]

Company Overview - Conagra Brands, Inc. (CAG) has a market cap of $8.7 billion and is a leading North American packaged foods company with a diverse portfolio including brands like Birds Eye, Healthy Choice, Slim Jim, Reddi-wip, and Marie Callender's [1] - The company operates across four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice, focusing on innovative food products that cater to changing consumer preferences [1] Financial Performance - Conagra Brands is set to announce its Q1 2026 results on October 1, with analysts expecting an adjusted EPS of $0.33, a decrease of 37.7% from $0.53 in the same quarter last year [2] - For fiscal 2026, analysts forecast an adjusted EPS of $1.73, representing a 24.8% decrease from $2.30 in fiscal 2025, but anticipate an 8.7% year-over-year growth to $1.88 in fiscal 2027 [3] Stock Performance - Shares of Conagra Brands have declined over 44% in the past 52 weeks, underperforming the S&P 500 Index's 15.4% return and the Consumer Staples Select Sector SPDR Fund's 5.9% decline [4] - Following the release of weak Q4 2025 results, shares fell 4.4%, with adjusted EPS of $0.56 missing consensus estimates and net sales of $2.8 billion down 4.3% year-over-year [5] Analyst Sentiment - The consensus view on CAG stock is cautious, with a "Hold" rating from 17 analysts; two recommend "Strong Buy," 12 suggest "Hold," one advises "Moderate Sell," and two "Strong Sells" [6] - The average analyst price target for Conagra Brands is $20.47, indicating a potential upside of 13.2% from current levels [6]

Group 1 - Conagra Brands, Inc. is facing challenges due to 7% inflation and issues with tin can supply, which are negatively impacting its margins [2] - The company has a portfolio of well-known brands, including Slim Jim, Marie Callender's, and Duncan Hines, but is struggling to pass on price increases to consumers [2] - Despite these challenges, Conagra has indicated that it can maintain its dividend payments, although concerns about the sustainability of dividends are raised [2] Group 2 - Jim Cramer emphasizes the importance of growth in stocks over high dividends, suggesting that high dividends may indicate underlying problems within the company [1] - The overall sentiment is that while Conagra has potential, other sectors, particularly AI stocks, may offer better investment opportunities with less risk [2]

Group 1 - Conagra Brands, Inc. (CAG) is valued at a market cap of $8.9 billion and operates over 70 iconic brands across various segments including grocery, snacks, and foodservice [1][2] - CAG is classified as a mid-cap stock, highlighting its size and influence in the packaged foods industry, and it focuses on brand modernization and product innovation to maintain market relevance [2] - The company's shares have retreated 44.3% from their 52-week high of $32.90, with a 14.8% decline over the past three months, underperforming the Nasdaq Food & Beverage ETF [3][4] Group 2 - Over the past 52 weeks, CAG shares have fallen 43.3%, significantly underperforming the FTXG's 16.1% drop, and are down 34% year-to-date compared to FTXG's 6.3% decline [4] - Following disappointing Q4 results, where revenue was $2.8 billion and adjusted EPS was $0.56, CAG's shares fell 4.4%, with year-over-year declines attributed to various economic pressures [5] - Analysts remain cautious about CAG's prospects, with a consensus rating of "Hold" and a mean price target of $20.60, indicating a 12.4% premium to current price levels [6]

Group 1: Company Overview - Conagra Brands is a consumer staples company with a market cap of around $9 billion, producing packaged food products under notable brands like Slim Jim, Hunts, Healthy Choice, and Duncan Hines [2] - The company is considered a second-tier player in the packaged food space, which implies it may face challenges in a market where quality is prioritized over value [4] Group 2: Financial Performance - Over the past year, Conagra's stock has lost a third of its value, indicating underlying issues within the company [5] - The company's gross profit margin has been declining since reaching a peak in 2023, coinciding with the stock's downward trend [5] - Revenue has also been trending lower, suggesting that Conagra's brand portfolio is not resonating well with consumers, complicating the gross profit margin situation [6] Group 3: Recent Results and Guidance - In the fiscal fourth quarter of 2025, Conagra experienced a 4.3% drop in sales and a 3.5% decline in organic sales, both worse than the full-year fiscal 2025 figures [7] - Guidance for fiscal 2026 indicates that organic sales are expected to be roughly flat, with a projected decline in adjusted operating margin and materially lower earnings [8] Group 4: Investment Considerations - While Conagra is likely to survive its current challenges, it may not be an attractive investment for most, particularly conservative dividend investors, due to a high adjusted earnings dividend payout ratio projected to be as high as 80% in fiscal 2026 [10] - The lack of a dividend increase since the second quarter of fiscal 2024 further underscores concerns regarding the company's financial health [10]